Quick Answer
Zymeworks Inc. reported Operating Income of -$92.55 million for fiscal year 2025.
Zymeworks Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$92.55M | +32.5% |
| 2024 | -$137.11M | +0.7% |
| 2023 | -$138.05M | -205.8% |
| 2022 | $130.53M | +160.5% |
| 2021 | -$215.63M | -15.0% |
| 2020 | -$187.47M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$22.11M | +35.4% | -3180.4% |
| June 30, 2025 | -$674.0K | +98.4% | +97.4% |
| March 31, 2025 | -$25.61M | +32.2% | +25.1% |
| September 30, 2024 | -$34.20M | -2.9% | +20.2% |
| June 30, 2024 | -$42.89M | +20.7% | -13.4% |
| March 31, 2024 | -$37.80M | -38.6% | -13.7% |
| September 30, 2023 | -$33.24M | +34.0% | +38.6% |
| June 30, 2023 | -$54.11M | +17.8% | -98.4% |
- Zymeworks Inc. showed an increase of +32.5% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Zymeworks Inc.’s operating income has grown by 50.6% (from -$187.47 million to -$92.55 million).
- The most recent figure is from Zymeworks Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 2, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: